Preference among female Army recruits for use of self-administrated vaginal swabs or urine to screen for Chlamydia trachomatis genital infections

Yu-Hsiang Hsieh, M. R. Howell, J. C. Gaydos, K. T. McKee, Thomas C Quinn, Charlotte A Gaydos

Research output: Contribution to journalArticle

Abstract

Use of self-administered vaginal swabs (SAS) for the detection of Chlamydia trachomatis by nucleic acid amplification tests simplifies specimen collection and transport, especially for women in nonclinical settings. Goal: We investigated the preference and comfort level of military women for the collection of SAS, compared with urine, for the diagnosis of genital chlamydial infections. Study Design: During March through August 1999, female Army recruits in basic training at Fort Jackson, South Carolina, were invited to participate in the study. Participants were requested to complete a questionnaire after providing both first-void urine (FVU) and SAS specimens. Participant characteristics, preferences, and comfort levels were assessed using multivariate logistic regression. Results: From 4496 eligible female recruits, 1403 (31%) completed questionnaires and 1382 provided both specimens; 11.8% (166 of 1403) of participants were infected with chlamydia. The relative sensitivity and specificity of the C. trachomatis Ligase Chain Reaction test on SAS in 1382 matched pairs was 81.1% and 98.6%, respectively, using the test result on urine specimens as the comparison standard. Most of the participants (90.8%) reported that they felt comfortable collecting the FVU specimen, and 69.6% indicated that they felt comfortable collecting SAS. Either specimen collection type received high acceptability at home and in the field, and more women reported that they would collect FVU than reported they would collect SAS in the future (in the field: FVU: 79.4%, SAS: 68.8%, P

Original languageEnglish (US)
Pages (from-to)769-773
Number of pages5
JournalSexually Transmitted Diseases
Volume30
Issue number10
DOIs
StatePublished - Oct 1 2003

Fingerprint

Chlamydia trachomatis
Urine
Infection
Specimen Handling
Ligase Chain Reaction
Nucleic Acid Amplification Techniques
Chlamydia
Logistic Models
Sensitivity and Specificity

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Microbiology (medical)

Cite this

@article{3274fc1be5bc4d0cb3c517bd25b2bd84,
title = "Preference among female Army recruits for use of self-administrated vaginal swabs or urine to screen for Chlamydia trachomatis genital infections",
abstract = "Use of self-administered vaginal swabs (SAS) for the detection of Chlamydia trachomatis by nucleic acid amplification tests simplifies specimen collection and transport, especially for women in nonclinical settings. Goal: We investigated the preference and comfort level of military women for the collection of SAS, compared with urine, for the diagnosis of genital chlamydial infections. Study Design: During March through August 1999, female Army recruits in basic training at Fort Jackson, South Carolina, were invited to participate in the study. Participants were requested to complete a questionnaire after providing both first-void urine (FVU) and SAS specimens. Participant characteristics, preferences, and comfort levels were assessed using multivariate logistic regression. Results: From 4496 eligible female recruits, 1403 (31{\%}) completed questionnaires and 1382 provided both specimens; 11.8{\%} (166 of 1403) of participants were infected with chlamydia. The relative sensitivity and specificity of the C. trachomatis Ligase Chain Reaction test on SAS in 1382 matched pairs was 81.1{\%} and 98.6{\%}, respectively, using the test result on urine specimens as the comparison standard. Most of the participants (90.8{\%}) reported that they felt comfortable collecting the FVU specimen, and 69.6{\%} indicated that they felt comfortable collecting SAS. Either specimen collection type received high acceptability at home and in the field, and more women reported that they would collect FVU than reported they would collect SAS in the future (in the field: FVU: 79.4{\%}, SAS: 68.8{\%}, P",
author = "Yu-Hsiang Hsieh and Howell, {M. R.} and Gaydos, {J. C.} and McKee, {K. T.} and Quinn, {Thomas C} and Gaydos, {Charlotte A}",
year = "2003",
month = "10",
day = "1",
doi = "10.1097/01.OLQ.0000079048.11771.46",
language = "English (US)",
volume = "30",
pages = "769--773",
journal = "Sexually Transmitted Diseases",
issn = "0148-5717",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Preference among female Army recruits for use of self-administrated vaginal swabs or urine to screen for Chlamydia trachomatis genital infections

AU - Hsieh, Yu-Hsiang

AU - Howell, M. R.

AU - Gaydos, J. C.

AU - McKee, K. T.

AU - Quinn, Thomas C

AU - Gaydos, Charlotte A

PY - 2003/10/1

Y1 - 2003/10/1

N2 - Use of self-administered vaginal swabs (SAS) for the detection of Chlamydia trachomatis by nucleic acid amplification tests simplifies specimen collection and transport, especially for women in nonclinical settings. Goal: We investigated the preference and comfort level of military women for the collection of SAS, compared with urine, for the diagnosis of genital chlamydial infections. Study Design: During March through August 1999, female Army recruits in basic training at Fort Jackson, South Carolina, were invited to participate in the study. Participants were requested to complete a questionnaire after providing both first-void urine (FVU) and SAS specimens. Participant characteristics, preferences, and comfort levels were assessed using multivariate logistic regression. Results: From 4496 eligible female recruits, 1403 (31%) completed questionnaires and 1382 provided both specimens; 11.8% (166 of 1403) of participants were infected with chlamydia. The relative sensitivity and specificity of the C. trachomatis Ligase Chain Reaction test on SAS in 1382 matched pairs was 81.1% and 98.6%, respectively, using the test result on urine specimens as the comparison standard. Most of the participants (90.8%) reported that they felt comfortable collecting the FVU specimen, and 69.6% indicated that they felt comfortable collecting SAS. Either specimen collection type received high acceptability at home and in the field, and more women reported that they would collect FVU than reported they would collect SAS in the future (in the field: FVU: 79.4%, SAS: 68.8%, P

AB - Use of self-administered vaginal swabs (SAS) for the detection of Chlamydia trachomatis by nucleic acid amplification tests simplifies specimen collection and transport, especially for women in nonclinical settings. Goal: We investigated the preference and comfort level of military women for the collection of SAS, compared with urine, for the diagnosis of genital chlamydial infections. Study Design: During March through August 1999, female Army recruits in basic training at Fort Jackson, South Carolina, were invited to participate in the study. Participants were requested to complete a questionnaire after providing both first-void urine (FVU) and SAS specimens. Participant characteristics, preferences, and comfort levels were assessed using multivariate logistic regression. Results: From 4496 eligible female recruits, 1403 (31%) completed questionnaires and 1382 provided both specimens; 11.8% (166 of 1403) of participants were infected with chlamydia. The relative sensitivity and specificity of the C. trachomatis Ligase Chain Reaction test on SAS in 1382 matched pairs was 81.1% and 98.6%, respectively, using the test result on urine specimens as the comparison standard. Most of the participants (90.8%) reported that they felt comfortable collecting the FVU specimen, and 69.6% indicated that they felt comfortable collecting SAS. Either specimen collection type received high acceptability at home and in the field, and more women reported that they would collect FVU than reported they would collect SAS in the future (in the field: FVU: 79.4%, SAS: 68.8%, P

UR - http://www.scopus.com/inward/record.url?scp=0141891281&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141891281&partnerID=8YFLogxK

U2 - 10.1097/01.OLQ.0000079048.11771.46

DO - 10.1097/01.OLQ.0000079048.11771.46

M3 - Article

C2 - 14520176

AN - SCOPUS:0141891281

VL - 30

SP - 769

EP - 773

JO - Sexually Transmitted Diseases

JF - Sexually Transmitted Diseases

SN - 0148-5717

IS - 10

ER -